REFERENCES
- Shneider BL, Brown MB, Haber B, A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148:467–474.
- Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009;374:1704.
- Selmi C, Vergani D, Miele-Vergani G. Viruses and autoantibodies in biliary atresia. Gastroenterology 2010;139:1461.
- Zhao R, Li H, Shen C, Hepatic portocholecystectostomy (HPC) is ineffective in the treatment of biliary atresia with patent distal extrahepatic bile ducts. J Invest Surg. 2011;24:53–58.
- Suzuki T, Hashimoto T, Kondo S, Evaluating patients’ outcome post-Kasai operation: a 19-year experience with modification of the hepatic portoenterostomy and applying a novel steroid therapy regimen. Pediatr Surg Int. 2010;26:825–830.
- Liu C, Chiu JH, Chin T, Expression of fas ligand on bile ductile epithelium in biliary atresia—a poor prognostic factor. J Pediatr Surg. 2000;35:1591–1596.
- Liu C, Chiu JH, Chin T, Expression of aminopeptidase N in bile canaliculi: a predictor of clinical outcome in biliary atresia and a potential tool to implicate the mechanism of biliary atresia. J Surg Res. 2001;100:76–83.
- Lao OB, Larison C, Garrison M, Steroid use after the Kasai procedure for biliary atresia. Am J Surg. 2010;199:680–684.
- de Vires W, de Langen ZJ, Aronson DC, Mortality of biliary atresia in children not undergoing liver transplantation in the Netherlands. Pediatr Transplant. 2011;15:176–183.
- Haafiz AB. Liver fibrosis in biliary atresia. Expert Rev Gastroenterol Hepatol. 2010;4:335.
- Mizuta K, Sanada Y, Wakiya T, Living-donor liver transplantation in 126 patients with biliary atresia: single-center experience. Transplant Proc. 2010;42:4127–4131.
- Chen CL, Concejero A, Wang CC, Living donor liver transplantation for biliary atresia: a single-center experience with first 100 cases. Am J Transplant. 2006;6:2672–2679.
- D'Alessandro AM, Knechtle SJ, Chin LT, Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin. Pediatr Transplant. 2007;11:661–670.
- Liu C, Loong C-C, Hsia C-Y, Retrograde arterial flush of the liver graft in living donor liver transplantation. J Invest Surg. 2009;22:406–412.
- Dienstag JL, Goldin RD, Heathcote EJ, Histological outcome during long-term lamivudine therapy. Gastroenterology 2003;124:105–117.
- Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med. 2003;348:800–807.
- Lai CL, Chien RN, Leung NW, A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med. 1998;339:61–68.
- Poynard T, McHutchison J, Manns, M Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology. 2003;38:481–492.
- Riepenhoff-Talty M, Schaekel K, Clark HF, Group A rotavirus produce extrahepatic biliary obstruction in orally inoculated new-born mice. Pediatr Res. 1993;33:394–399.
- Petersen C, Biermanns D, Kuske M, New aspects in a murine model for extrahepatic biliary atresia. J Pediatr Surg. 1997;32:1190–1195.
- Petersen C, Grasshoff S, Luciano L. Diverse morphology of biliary atresia in an animal model. J Hepatol. 1998;28:603.
- Czech-Schmidt G, Verhagen W, Szavay P, Immunological gap in the infectious animal model for biliary atresia. J Surg Res. 2001;101:62–67.
- Lu BR, Brindley SM, Tucker RM, Enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia. Gastroenterology 2010;139:1753–1761.
- Aller MA, Duran M, Ortega L, Comparative study of macro- and microsurgical extrahepatic cholestasis in the rat. Microsurgery 2004;24:442–447.
- Sanchez-Patan F, Anchuelo R, Corcuera M-T, Biliary fibrosis in microsurgical extrahepatic cholestasis in the rat. Microsurgery 2008;28:361–366.
- Gibelli NE, Tannuri U, de Mello ES, Bile duct ligation in neonatal rats: is it a valid experimental model for biliary atresia studies? Pediatr Transplant. 2009;13:81–87.
- Chuang JH, Chang NK, Huang CC, Biliary intervention augments chemotactic reaction and aggravates cholestatic liver injury in rats. J Surg Res. 2004;120:210–218.
- Hsieh CS, Wang PW, Lee SY, Glucocorticoid pretreatment suppresses chemokines expression and inflammatory cell infiltration in cholestatic rats receiving biliary intervention. J Pediatr Surg. 2006;41:1669–1675.
- Petersen C. Biliary atresia: the animal models. Semi Pediatr Surg. 2012;21:185–191.
- Ishak K, Baptosta A, Bianchi L, Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–699.
- Matsumoto T, Iwaki K, Hagino Y, Ethanol injection therapy of an isolated bile duct associated with a biliary-cutaneous fistula. J Gastroenterol Hepatol. 2002;17:807–810.
- Kyokane T, Nagino M, Oda K, An experimental study of selective intrahepatic biliary ablation with ethanol. J Surg Res. 2001;96:188–196.
- Kyokane T, Nagino M, Sano T, Ethanol ablation for segmental bile duct leakage after hepatobiliary resection. Surgery. 2002;131:111–113.
- Liu D, Gomes AS, McDiarmid SV. Successful treatment of isolated draining intrahepatic biliary ducts in a pediatric liver transplant recipient using alcohol sclerotherapy. J Vasc Inter Radiol. 2008;19:121–123.